Trial on S-ICD Implantation Without Defibrillation Testing Shows Non-Inferiority
A randomized trial is assessing whether S-ICD implantation without defibrillation testing is non-inferior to the standard method.
Phase III
Cardiology / Device Therapy
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The trial results on S-ICD implantation without defibrillation testing could significantly influence clinical practices and device adoption in cardiology. If proven non-inferior, this approach may lead to a shift towards less invasive procedures, affecting market dynamics and competitive positioning.
Recommended action
Humanexa recommends Monitor: Monitoring is recommended to stay informed on trial outcomes and subsequent guideline changes, which could impact strategic decisions and market positioning.
Analysis
Monitor trial results and subsequent guidelines from cardiology associations regarding S-ICD implantation practices.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.